Food and Drug Administration (FDA) news from FierceHealthcare
News
ALSO NOTED: FDA may require side-effects hotline number in DTC ads; Many uninsured could be eligible for gov't insurance; and m
> An FDA panel is considering whether it should require direct-to-consumer advertisers to include a side-effects hotline in every commercial. Read more...
ALSO NOTED: PA schedules hearings on Independence/Highmark merger; Medical college group urges caution with pharma tech freebie
> More than a year after the deal was proposed, the Pennsylvania Insurance Department has (finally) scheduled hearings to review public comments on the proposed merger of Independence Blue Cross Read more...
FDA says hospitals may still have recalled heparin
Despite widespread publicity about heparin problems, several California hospitals were found to still have recalled heparin products in their supply chains, suggesting that the problem could still be Read more...
Group asks FDA to pull birth control patch off market
Arguing that it's a far riskier treatment than the pill, consumer advocacy group Public Citizen has asked the FDA to pull the birth control patch Ortho-Evra off the market. Over the last few years, Read more...
ALSO NOTED: Tenet reports $31M loss for quarter; FDA rules against broader Fentora use; and much more...
> Tenet has reported a $31 million loss for the first quarter of this year. FierceHealthFinance Read more...
ALSO NOTED: FDA admits it can't afford to boost foreign inspections; Researchers test anti-smoking vaccine; and much more...
> The FDA has conceded that maybe, just maybe, it will need more money if it's going to do a good job of inspecting foreign drug manufacture sites. Read more...
ALSO NOTED: U of Miami suffers massive patient data loss; Loyola U sets $1B strategic plan; and much more...
> The University of Miami School of Medicine has lost data backup tapes containing data on 2.1 million patients. Read more...
SPOTLIGHT: FDA can't manage foreign drugmaker inspections
A new report from the Government Accountability Office has concluded that the FDA doesn't have the resources to properly inspect foreign companies that manufacture drugs or drug ingredients. At Read more...
ALSO NOTED: Revenue growth slows for PA hospitals, but they remain profitable; JAMA rips journal use for off-label pharma marke
> Revenue growth has slowed for Pennsylvania hospitals, but still continues, and they continue to enjoy relatively healthy margins. Read more...
Reports suggest that Merck downplayed Vioxx risks
Another day, another report suggesting that a pharmaceutical company tried to bury data impugning the safety of one of its products. This time, a study has been published in The Journal of the Read more...
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies